Abstract 291P
Background
Malnutrition is one of the most frequent disorders in cancer patients which accounts for 50-90%. This high prevalence of malnutrition is very concerning as it is associated with reduced treatment efficacy, functional status, quality of life and survival. The prevalence of malnutrition varies with tumor type, site and the stage of the disease. The highest prevalence of cancer patients with nutritional deficits is seen in those with tumors of the gastrointestinal tract and lung.
Methods
It is a hospital based cross sectional study among 95 cancer patients. They were screened using Patient Generated Subjective Global Assessment (PGSGA) for malnutrition. Median and IQR were used to describe the continuous data and frequency and percentage for the categorical variables. To identify the correlation between continuous variables, Pearson’s correlation coefficient was used. At 95% confidence interval, p value less than 0.05 was termed as statistically significant. The data were analyzed using SPSS 20.0 software.
Results
Among 95 patients, 36.85% of patients were GI cancers followed by 27.37% lung cancer, breast cancer (10.53%) and rectal cancer (10.53%). Most of the patients (81.05%) were well nourished Subjective Global Assessment (SGA-A), 13.68% patients were moderately malnourished or had suspected malnutrition (SGA-B) and 5.26% patients were severely malnourished (SGA-C). There was statistically significant difference in association of malnutrition with gastrointestinal cancer. Among equally distributed limited and metastatic cancers, there was no significant association between stages of cancer with malnutrition.
Conclusions
Nutritional assessment and support should be an integral part of care in gastrointestinal cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The author.
Funding
Has not received any funding.
Disclosure
The author has declared no conflicts of interest.
Resources from the same session
281P - Cancer-related symptoms as mediators between treatment and functional capacity in adolescents and young adults (AYAs) with cancer
Presenter: Chung Tin Justin Ma
Session: Poster viewing 04
282P - Nutritional status and nutritional therapy of common cancer in a cancer hospital of Southwest China
Presenter: Huiqing Yu
Session: Poster viewing 04
283P - Comparative analysis of osteoporotic fracture (OF) and pathologic fracture (PF) in patients with metastatic colorectal cancer (mCRC) who received palliative chemotherapy
Presenter: Yejee Lim
Session: Poster viewing 04
284P - Gut microbiota mediates the protective effects of resveratrol against the intestinal barrier dysfunction in non-alcoholic steatohepatitis induced by high-fat diet
Presenter: Haoyang Cao
Session: Poster viewing 04
285P - Reticulocyte hemoglobin equivalent as an early predictor of iron deficiency anemia in cancer patients
Presenter: Aditya Sarin
Session: Poster viewing 04
286P - Breakthrough COVID-19 infections in patients with cancer from a prospective study of COVID-19 vaccine response
Presenter: Amy Body
Session: Poster viewing 04
287P - Long-term yoga enhances the quality of life and symptomatic scale in breast cancer patients undergoing treatment
Presenter: Mayank Jain
Session: Poster viewing 04
288P - Impact of hormonal contraception on estradiol and progesterone serum levels: A 6-year study on progression-free survival, disease-free survival, and overall survival at Dr. Moewardi Hospital
Presenter: Widyanti Soewoto
Session: Poster viewing 04
289P - Cancer cachexia following breast cancer (BC) chemotherapy was associated with clinical stage, number of chemotherapy cycles, and vitamin D concentration
Presenter: Susanna Hutajulu
Session: Poster viewing 04
290P - Use of PEG G-CSF is associated with decreased myelotoxicity in dexrazoxane-used aggressive non-Hodgkin lymphoma patients
Presenter: Sung-Nam Lim
Session: Poster viewing 04